Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
By
Peter Hess
13 July 2021 | 6 min read
Explore more from The Transmitter
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read
Learning why spiny mice play well with others
Aubrey Kelly studies the gregarious mammal to explore how the brain controls complex social behaviors “akin to friendship.”
Learning why spiny mice play well with others
Aubrey Kelly studies the gregarious mammal to explore how the brain controls complex social behaviors “akin to friendship.”
By
Hannah Thomasy
2 June 2026 | 5 min read
Autism-linked genes expressed in thalamus make an impact, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 June.
Autism-linked genes expressed in thalamus make an impact, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 June.
By
Jill Adams
2 June 2026 | 2 min read